Jacob, Josephine
Tesch, Falko http://orcid.org/0000-0001-8933-643X
Wende, Danny
Batram, Manuel
Loser, Friedrich
Weidinger, Oliver
Roessler, Martin
Seifert, Martin
Risch, Lisa
Nagel, Oliver
König, Christina
Jucknewitz, Roland
Treskova-Schwarzbach, Marina
Hertle, Dagmar
Scholz, Stefan
Stern, Stefan
Ballesteros, Pedro
Baßler, Stefan
Bertele, Barbara
Repschläger, Uwe
Richter, Nico
Riederer, Cordula
Sobik, Franziska
Schramm, Anja
Schulte, Claudia
Walker, Jochen
Schmitt, Jochen
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 18 October 2022
Accepted: 3 March 2023
First Online: 22 March 2023
Declarations
:
: The ethics committee of TU Dresden approved this study (approval number: BO-EK (COVID)-482102021).
: Not applicable.
: Not applicable.
: FT, JJ, JS, JW, MR, MS, and ON report institutional funding for parts of this project from the German BMBF. Unrelated to this study, JS reports grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU, Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He also participated in advisory board meetings for Sanofi, Lilly, and ALK. MB reports payment for data analysis which is presented in this paper from DAK-Gesundheit. Unrelated to this study, MB reports grants from German GBA, Pfizer, and Sanofi Pasteur and consulting fees from Janssen-Cilag. He participated in an advisory board for GSK. SB is Head of Analytics and Data Science at AOK PLUS, Dresden, Germany. The other authors declare that they have no competing interest.